0001209191-21-054490.txt : 20210902
0001209191-21-054490.hdr.sgml : 20210902
20210902170517
ACCESSION NUMBER: 0001209191-21-054490
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210901
FILED AS OF DATE: 20210902
DATE AS OF CHANGE: 20210902
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Knight Jeff E.
CENTRAL INDEX KEY: 0001881007
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38583
FILM NUMBER: 211234071
MAIL ADDRESS:
STREET 1: CRINETICS PHARMACEUTICALS, INC.
STREET 2: 10222 BARNES CANYON ROAD, BUILDING 2
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Crinetics Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001658247
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 263744114
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10222 BARNES CANYON ROAD, BLDG. #2
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-450-6464
MAIL ADDRESS:
STREET 1: 10222 BARNES CANYON ROAD, BLDG. #2
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-09-01
0
0001658247
Crinetics Pharmaceuticals, Inc.
CRNX
0001881007
Knight Jeff E.
C/O CRINETICS PHARMACEUTICALS, INC.
10222 BARNES CANYON ROAD, BLDG 2
SAN DIEGO
CA
92121
0
1
0
0
Chief Operating Officer
Stock Option (right to buy)
23.98
2021-09-01
4
A
0
160000
0.00
A
2031-08-30
Common Stock
160000
160000
D
The option is exercisable as follows: 25% of the shares subject to the option vest on August 30, 2022, and the remaining number of shares subject to the option vest monthly thereafter in thirty-six equal installments, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.
/s/ Marc Wilson, as attorney-in-fact
2021-09-02